PCN19 Cost-Effectiveness Analysis of Temsirolimus in Patients With Poor Risk Renal-Cell Carcinoma
Abstract
Authors
H.C. Kan R.F. Pwu
H.C. Kan R.F. Pwu
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now